Literature DB >> 10634631

Short-wavelength automated perimetry and capillary density in early diabetic maculopathy.

A Remky1, O Arend, S Hendricks.   

Abstract

PURPOSE: To correlate short-wavelength cone-mediated sensitivity (SWS) assessed by blue-on-yellow perimetry with alterations of the perifoveal vascular bed in early diabetic maculopathy.
METHODS: Thirty-one patients (21 M, 10 F; mean age, 35 +/- 12 years; no lens opacities) with no clinically significant macular edema were included in this study. All patients underwent short-wavelength automated perimetry (SWAP) and conventional white-on-white perimetry (Humphrey, 10-2). In digitized video fluorescein angiograms (Scanning Laser Ophthalmoscope), the size of the foveal avascular zone (FAZ) and the mean perifoveal intercapillary area (PIA) as a measure of capillary density were quantified interactively.
RESULTS: Mean thresholds of SWAP were significantly correlated with increasing size of FAZ (r = -0.51, P = 0.003) and PIA (r = -0.47, P = 0.01), whereas visual acuity expressed by log MAR (FAZ: r = 0.15, P = 0.41; PIA: r = 0.06, P = 0.76) and mean thresholds assessed with white-on-white perimetry (FAZ: r = -0.25, P = 0.20; PIA: r = -0.31, P = 0.14) were unrelated to diabetic changes of the perifoveal capillary network.
CONCLUSIONS: The alterations of the perifoveal network are related to selective disturbances of visual function as measured by blue-on-yellow-perimetry. SWAP may act as an early detector of visual function loss in early diabetic maculopathy and serve as a helpful technique to predict early ischemic damage of the macula and to monitor therapy.

Entities:  

Mesh:

Year:  2000        PMID: 10634631

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

Review 1.  [Functional glaucoma diagnosis].

Authors:  C Erb; K Göbel
Journal:  Ophthalmologe       Date:  2009-04       Impact factor: 1.059

2.  Visual acuity and perimetry as measures of visual function in diabetic macular oedema.

Authors:  E Agardh; H Stjernquist; A Heijl; B Bengtsson
Journal:  Diabetologia       Date:  2005-12-10       Impact factor: 10.122

3.  Blue on yellow perimetry with scanning laser ophthalmoscopy in patients with age related macular disease.

Authors:  A Remky; A E Elsner
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

4.  Short wavelength automated perimetry in age related maculopathy.

Authors:  A Remky; K Lichtenberg; A E Elsner; O Arend
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

5.  Visual fields correlate better than visual acuity to severity of diabetic retinopathy.

Authors:  B Bengtsson; A Heijl; E Agardh
Journal:  Diabetologia       Date:  2005-11-01       Impact factor: 10.122

6.  Frequency of seeing characteristics of the short wavelength sensitive visual pathway in clinically normal subjects and diabetic patients with focal sensitivity loss.

Authors:  E D Gilmore; C Hudson; R K Nrusimhadevara; P T Harvey
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

7.  Evaluation of S-cone sensitivity in reattached macula following macula-off retinal detachment surgery.

Authors:  Tsutomu Sakai; Kazuyuki Iida; Yuichiro Tanaka; Kenichi Kohzaki; Kenji Kitahara
Journal:  Jpn J Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 2.447

8.  Variability in short-wavelength automated perimetry among peri- or postmenopausal women: a dependence on phyto-oestrogen consumption?

Authors:  Alvin Eisner; Shaban Demirel
Journal:  Acta Ophthalmol       Date:  2011-05       Impact factor: 3.761

9.  Short-wavelength automated perimetry in patients with diabetes mellitus without macular edema.

Authors:  Andreas Remky; Anke Weber; Stefan Hendricks; Kristina Lichtenberg; Oliver Arend
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-17       Impact factor: 3.117

10.  Quantification of visual field loss in age-related macular degeneration.

Authors:  Jennifer H Acton; Jonathan M Gibson; Robert P Cubbidge
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.